Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose‐intensive chemotherapy including rituximab

16 Nov 2015

Abstract excerpt

The introduction of Rituximab has improved the outcome and survival rates of Burkitt lymphoma (BL). However, early relapse and refractoriness are current limitations of BL treatment and new biological factors affecting the outcome of these patients have not been explored. This study aimed to identify the presence of genomic changes that could predict the response to new therapies in BL. Forty adolescent and adult...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26567765
DOI: 10.1111/bjh.13849

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose‐intensive chemotherapy including rituximabPMID 26567765Read ↗

Genetic differences between paediatric and adult Burkitt lymphomasSemantic proximity Read ↗

Burkitt lymphoma: bridging the gap between advances in molecular biology and therapySemantic proximity Read ↗

New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.Semantic proximity Read ↗

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.Semantic proximity Read ↗

High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's LymphomaSemantic proximity Read ↗

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphomaSemantic proximity Read ↗

The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.Semantic proximity Read ↗

The treatment of Burkitt lymphoma in adults.Semantic proximity Read ↗

Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression.Semantic proximity Read ↗

Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B‐cell lymphomasSemantic proximity Read ↗

Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group reportSemantic proximity Read ↗

Secondary chromosomal abnormalities predict outcome in pediatric and adult high‐stage Burkitt lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.